Advertisement

Neuroethics

, Volume 7, Issue 3, pp 373–375 | Cite as

Enhancing Autonomy by Reducing Impulsivity: The Case of ADHD

  • Jonathan PughEmail author
Brief Communication

Abstract

In a recent article in this journal, Schaefer et al. argue that it might be possible to enhance autonomy through the use of cognitive enhancements. In this article, I highlight an example that Schaefer et al. do not acknowledge of a way in which we already seem to be using pharmacological agents in a manner that can be understood as enhancing an agent’s autonomy. To make this argument, I begin by following other theorists in the philosophical literature in claiming that impulsivity can serve to undermine an agent’s autonomy. I then explain that we are already able to reduce impulsivity through the use of pharmacological interventions, as is evidenced by the use of Methylphenidate in the treatment of ADHD.

Keywords

Autonomy Enhancement Cognition Impulsivity 

Notes

Acknowledgments

I thank Julian Savulescu, Roger Crisp, Neil Levy and an anonymous reviewer for helpful comments on a previous draft of this paper.

References

  1. 1.
    Schaefer, G. O., Kahane, G., and Savulescu, J. 2013. Autonomy and Enhancement. Neuroethics (Online First) 1–14. doi: 10.1007/s12152-013-9189-5
  2. 2.
    Frankfurt, H.G. 1971. Freedom of the will and the concept of a person. Journal of Philosophy 68: 5–20.CrossRefGoogle Scholar
  3. 3.
    Watson, G. 1975. Free agency. Journal of Philosophy 72: 205–220.CrossRefGoogle Scholar
  4. 4.
    Ekstrom, L.W. 1993. A coherence theory of autonomy. Philosophy and Phenomenological Research 53: 599–616.CrossRefGoogle Scholar
  5. 5.
    Bratman, M. Planning agency, autonomous agency. In Pers. Auton. New Essays Pers. Auton. Its Role Contemp. Moral Philos, ed. J. S. Taylor. Cambridge: Cambridge University PressGoogle Scholar
  6. 6.
    Singh, Ilina. 2008. Beyond polemics: science and ethics of ADHD. Nature Reviews Neuroscience 9: 957–964.CrossRefGoogle Scholar
  7. 7.
    Singh, I. 2007. Not just naughty: 50 years of stimulant drug advertising. In Medicat. Mod. Am, ed. E.S. Watkins. New York: New York University Press.Google Scholar
  8. 8.
    Singh, I., and K. Kelleher. 2010. Neuroenhancement in young people: proposal for research, policy, and clinical management. AJOB Neuroscience 1: 3–16.CrossRefGoogle Scholar
  9. 9.
    Sandberg, A. 2011. Cognition enhancement: Upgrading the brain. In Enhancing Hum. Capacit, ed. J. Savulescu, G. Kahane, and R. ter Meulen. Oxford: Wiley-Blackwell.Google Scholar
  10. 10.
    Kreek, M.J., D.A. Nielsen, E.R. Butelman, and K.S. LaForge. 2005. Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nature Neuroscience 8: 1450–1457.CrossRefGoogle Scholar
  11. 11.
    Mobbs, O., C. Crépin, C. Thiéry, A. Golay, and M. Van der Linden. 2010. Obesity and the four facets of impulsivity. Patient Education and Counseling 79: 372–377.CrossRefGoogle Scholar
  12. 12.
    Savulescu, J., A. Sandberg, and G. Kahane. 2011. Well-being and enhancement. In Enhancing Hum. Capacit, ed. J. Savulescu, G. Kahane, and R. ter Meulen. Oxford: Wiley-Blackwell.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2014

Authors and Affiliations

  1. 1.Uehiro Centre for Practical EthicsUniversity of OxfordOxfordUK

Personalised recommendations